Although WNT5A is the dominant noncanonical WNT ligand in SSc, differences in the expression levels of other ligands may further enhance the activation of WNT/β-catenin–independent signaling, and other noncanonical WNT ligands may be dominant in other fibrotic diseases (59–61). The gene discussed is WNT5A; the disease is systemic sclerosis.